Ocko: Moleculo retains rights to all blinded genetic data processed
Matt Ocko · Panel: Big data and VCs (Accel, IA Ventures, Data Collective) // Data Driven NYC #8// Oct 2012 · Dec 5, 2013 · at 34:49
Matt Ocko, Partner at Data Collective, provides an example of a portfolio company building a proprietary data asset as a competitive moat.
0:00 / 0:11exact quote · 11.6s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Moleculo, they retain the rights to the blinded genetic data of every human or animal or plant that they are solving a problem for.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Matt Ocko
Matt Ocko: Data Collective got 2x-3x cash returns on failed investments
“In three years, in very, very high risk investing, our worst case outcome was 95% return on capital. And in the failed companies, we got two X, three X cash on cash returns.”
Ocko: Verticals where people die are aggressive buyers of big data tech
“The verticals where people die, or vast amounts of money are lost, if the right answer is not arrived at in increasingly smaller windows of time, are, in fact, the most aggressive customers for some of these technologies.”
Matt Ocko: Data Collective backed ZenPayroll to gut legacy incumbent ADP
“We're investors in a company called Zen Payroll, ah, and we're investors there because they demonstrated in, on a very small amount Really, of their own money, that they could gut ADP. That customers deserted ADP in droves to have essentially single click, ove…”
Matt Ocko predicts billion-dollar startups will solve core Hadoop infrastructure limits
“In each one of these, kind of, criteria, or vectors, or themes, there's a handful of billion dollar startups Ah yet to be, ah, yet to be built.”